Mirae Asset Global Investments
KYNB

Mirae Asset Global Investments’s Kyntra Bio KYNB Stock Holding History

Mirae Asset Global Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,232
Closed -$1.05M – 1884
2024
Q1 		$1.05M Buy
+2,232
New +$96.2K ﹤0.01% 1513
2023
Q4 		– Sell
-418
Closed -$9.01K – 2560
2023
Q3 		$9.01K Sell
418
-2,013
-83% -$79.1K ﹤0.01% 2566
2023
Q2 		$163K Sell
2,431
-267
-10% -$110K ﹤0.01% 2397
2023
Q1 		$1.26M Buy
2,698
+590
+28% +$312K ﹤0.01% 1428
2022
Q4 		$844K Buy
2,108
+150
+8% +$57.5K ﹤0.01% 1585
2022
Q3 		$636K Buy
1,958
+340
+21% +$109K ﹤0.01% 1733
2022
Q2 		$427K Buy
1,618
+1,176
+266% +$300K ﹤0.01% 1830
2022
Q1 		$133K Sell
442
-28
-6% -$9.76K ﹤0.01% 1554
2021
Q4 		$166K Buy
470
+8
+2% +$2.49K ﹤0.01% 1536
2021
Q3 		$118K Buy
462
+53
+13% +$18.8K ﹤0.01% 1720
2021
Q2 		$272K Buy
+409
New +$236K ﹤0.01% 1601

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Mirae Asset Global Investments's KYNB Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 2,232 shares — an estimated $1.05M sold.

Mirae Asset Global Investments first reported a position in KYNB in Q2 2021 and held it in 11 quarters. The position peaked at $1.26M in Q1 2023. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,232 Kyntra Bio shares in Q2 2024, an estimated $1.05M.
  • Mirae Asset Global Investments first reported a position in Kyntra Bio in Q2 2021 and held it in 11 quarters.
  • Mirae Asset Global Investments's Kyntra Bio position peaked at $1.26M in Q1 2023.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.